0001477932-15-002068.txt : 20150331 0001477932-15-002068.hdr.sgml : 20150331 20150331131343 ACCESSION NUMBER: 0001477932-15-002068 CONFORMED SUBMISSION TYPE: NT 10-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141231 FILED AS OF DATE: 20150331 DATE AS OF CHANGE: 20150331 EFFECTIVENESS DATE: 20150331 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sanomedics, Inc. CENTRAL INDEX KEY: 0001501972 STANDARD INDUSTRIAL CLASSIFICATION: MEASURING & CONTROLLING DEVICES, NEC [3829] IRS NUMBER: 273320809 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NT 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-54167 FILM NUMBER: 15737867 BUSINESS ADDRESS: STREET 1: 444 BRICKELL AVE. STREET 2: SUITE 415 CITY: MIAMI STATE: FL ZIP: 33131 BUSINESS PHONE: 305-433-7814 MAIL ADDRESS: STREET 1: 444 BRICKELL AVE. STREET 2: SUITE 415 CITY: MIAMI STATE: FL ZIP: 33131 FORMER COMPANY: FORMER CONFORMED NAME: Sanomedics International Holdings, Inc DATE OF NAME CHANGE: 20100923 NT 10-K 1 simh_nt10k.htm NT 10-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 12b-25

 

NOTIFICATION OF LATE FILING

 

SEC FILE NUMBER 000-54167

 

CUSIP NUMBER ________

(Check One):      x  Form 10-K      ¨  Form 20-F      ¨  Form 10-Q      ¨  Form 10-D      ¨  Form N-SAR

 

For Period Ended: December 31, 2014                              

 

¨ Transition Report on Form 10-K

¨ Transition Report on Form 20-F

¨ Transition Report on Form 11-K

¨ Transition Report on Form 10-Q

¨ Transition Report on Form N-SAR

 

For the Transition Period Ended: _________________

 

Read Instruction (on back page) Before Preparing Form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

 

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: ________________________

 

PART I -- REGISTRANT INFORMATION

 

Sanomedics, Inc.

Full Name of Registrant

 

Sanomedics International Holdings, Inc.

Former Name if Applicable

 

444 Brickell Ave, Suite 415

Address of Principle Executive Office (Street and Number)

 

Miami, Florida 33131

City, State and Zip Code

 

 

 

  

PART II -- RULES 12B-25(b) AND (c)

 

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

 

 

(a)

The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
 

 

  
x

(b)

The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K or Form N-SAR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
 

 

  
 

(c)

The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

 

PART III--NARRATIVE

 

State below in reasonable detail why forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, or the transition report or portion thereof, could not be filed within the prescribed time period.

 

The registrant is unable to file its Annual Report (the "Annual Report") on Form 10-K for its fiscal year ended December 31, 2014 by the prescribed date of March 31, 2015 due to a delay with finalizing its results of operations for such period. The registrant intends to file the Annual Report by April 15, 2015.

 

PART IV--OTHER INFORMATION

 

(1)

Name and telephone number of person to contact in regard to this notification

 

 

David C. Langle, CFO

305

433-7814

 

(Name)

  

(Area Code)

  

(Telephone Number)

 

(2)

Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).

 

x  Yes    ¨  No

  

(3)

Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

 

¨  Yes    x  No

 

 

 

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

  

 
2

 

Sanomedics, Inc.

(Name of Registrant as Specified in Charter)

 

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

 

       
Date: March 31, 2015 By: /s/ David C. Langle  
    David C. Langle  
    Chief Financial Officer  
       

 

INSTRUCTION: The form may be signed by an executive officer or the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative’s authority to sign on behalf of the registrant shall be filed with the form.

 

 

3